DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

STEMCELLS, INC. (NASDAQ: STEM)

0.42 -0.01 (-2.37%)

Quote as of


company name or ticker

Recent Quotes

STEM $0.42 -2.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.45
Previous Close $0.43
Daily Range $0.41 - $0.45
52-Week Range $0.39 - $1.70
Market Cap $44.2M
P/E Ratio -0.83
Dividend (Yield) $0.00 (0.0%)
Volume 438,993
Average Daily Volume 1,539,060
Current FY EPS -$0.41

Sector

Healthcare

Industry

Drug Makers

STEMCELLS, INC. (STEM) Description

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders. Website: http://www.stemcellsinc.com/

News & Commentary Rss Feed

Cloning: A Stem Cell Revolution?

Will the creation of cloned human stem cells create a treatment revolution and a profitable investment?

Neuralstem Wins Patent Infringement Case Vs. StemCell, Inc.; Moves Forward In Spinal Cord Injury

Health Care Sector Update for 07/20/2015: HRTX, ALNY, STEM

StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular Deg

StemCells, Inc. Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular Degeneration

The Race To Treat Spinal Cord Injury: A Comparative Analysis

Will StemCells (STEM) Continue to Surge Higher? - Tale of the Tape

Health Care Sector Update for 06/04/2015: RGLS, NVGN, STEM

StemCells (STEM) Worth Watching: Stock Rises 10.7% - Tale of the Tape

Cantor: Time To Buy StemCells

Benzinga's Top Initiations

HC Wainwright: Buy StemCells, It's Worth $1/Share

See More STEM News...

STEM's Top Competitors

STEM $0.42 (-2.37%)
Current stock: STEM
AMGN $174.80 (-0.45%)
Current stock: AMGN
GILD $118.87 (-0.61%)
Current stock: GILD
BIIB $330.38 (1.85%)
Current stock: BIIB